Associations between MDR1 C3435T polymorphism and drug-resistant epilepsy in the Polish population
暂无分享,去创建一个
Andrzej Marchel | H. Romanowicz | B. Smolarz | A. Rysz | M. Stasiołek | A. Marchel | Dominik Skalski | Janusz Wendorff | Hanna Romanowicz | Andrzej Rysz | Mariusz Stasiołek | Beata Smolarz | Dominik Skalski | J. Wendorff
[1] A. Quattrone,et al. Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy , 2015, Seizure.
[2] A. Sieron,et al. Polymorphism of ABCB1/MDR1 C3435T in Children and Adolescents with Partial Epilepsy is due to Different Criteria for Drug Resistance – Preliminary Results , 2014, Medical science monitor : international medical journal of experimental and clinical research.
[3] Ji-Wei Cheng,et al. Association between MDR1 C3435T polymorphism and refractory epilepsy in the Chinese population: A systematic review and meta-analysis , 2014, Epilepsy & Behavior.
[4] A. Munshi,et al. Significance of MDR1 gene polymorphism C3435T in predicting drug response in epilepsy , 2014, Epilepsy Research.
[5] İ. Erol,et al. Multidrug resistance 1 (MDR1) 3435C/T genotyping in childhood drug-resistant epilepsy , 2014, Brain and Development.
[6] The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children , 2013, Molecular Biology Reports.
[7] U. Das,et al. Role of MDR1 C3435T and GABRG2 C588T gene polymorphisms in seizure occurrence and MDR1 effect on anti-epileptic drug (phenytoin) absorption. , 2012, Genetic testing and molecular biomarkers.
[8] A. Lazarowski,et al. Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions , 2011, Drug metabolism and drug interactions.
[9] M. Schalling,et al. Multidrug Resistance 1 (MDR1) Gene Polymorphisms in Childhood Drug-Resistant Epilepsy , 2010, Journal of child neurology.
[10] E. Aronica,et al. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats , 2010, Neuropharmacology.
[11] P. Zill,et al. Letter: Lack of association between MDR1 polymorphisms and pharmacoresistance to anticonvulsive drugs in patients with childhood‐onset epilepsy , 2009, Epilepsia.
[12] G. Koren,et al. Polymorphism of the MDR1/ABCB1 C3435T drug‐transporter and resistance to anticonvulsant drugs: A meta‐analysis , 2009, Epilepsia.
[13] K. Satyamoorthy,et al. Analysis of genotype and haplotype effects of ABCB1 (MDR1) polymorphisms in the risk of medically refractory epilepsy in an Indian population. , 2009, Drug metabolism and pharmacokinetics.
[14] I. Cascorbi,et al. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients , 2008, Epilepsia.
[15] W. Sadee,et al. Searching for polymorphisms that affect gene expression and mRNA processing: Example ABCB1 (MDR1) , 2006, The AAPS Journal.
[16] N. Bebek,et al. Association of MDR1 (C3435T) Polymorphism and Resistance to Carbamazepine in Epileptic Patients from Turkey , 2007, European Neurology.
[17] P. Kwan,et al. Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese , 2007, Epilepsy & Behavior.
[18] D. Goldstein,et al. The role of common variation in drug transporter genes in refractory epilepsy , 2005, Expert opinion on pharmacotherapy.
[19] A. Vezzani,et al. Significance of MDR1 and multiple drug resistance in refractory human epileptic brain , 2004 .
[20] C. Baumgartner,et al. Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy , 2004, Neurology.
[21] I. Scheffer,et al. Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy , 2004, Neurology.
[22] D. Goldstein,et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. , 2003, The New England journal of medicine.
[23] R. Kim,et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans , 2001, Clinical pharmacology and therapeutics.
[24] J. Kigawa,et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. , 2001, The Journal of pharmacology and experimental therapeutics.
[25] U. Brinkmann,et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[26] N. Barbaro,et al. MDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy , 1995, Epilepsia.